Utilization of care among drug resistant epilepsy patients with symptoms of anxiety and depression

Seizure : the Journal of the British Epilepsy Association
Katherine T HamiltonJohn R Pollard

Abstract

Epilepsy patients have a significantly higher rate of anxiety and depression than the general population, and psychiatric disease is particularly prevalent among drug resistant epilepsy patients. Symptoms of anxiety and depression might serve as a barrier to appropriate epilepsy care. The aim of this study was to determine if drug resistant epilepsy patients with symptoms of anxiety and/or depression receive different epilepsy management than controls. We identified 83 patients with drug resistant focal epilepsy seen at the Penn Epilepsy Center. Upon enrollment, all patients completed 3 self-report scales and a neuropsychiatric inventory and were grouped into those with symptoms of anxiety and/or depression and controls. Each patient's medical records were retrospectively reviewed for 1-2 years, and objective measures of outpatient and inpatient epilepsy management were assessed. At baseline, 53% (n=43) of patients screened positive for symptoms of anxiety and/or depression. The remaining 47% (n=38) served as controls. Patients with anxiety and/or depression symptoms had more missed outpatient visits per year compared to controls (median 0.84 vs. 0.48, p=0.02). Patients with symptoms of both anxiety and depression were more lik...Continue Reading

References

Jul 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·J Edeh, B Toone
Sep 1, 1993·The Australian and New Zealand Journal of Psychiatry·P L MorrisJ Samuels
Mar 10, 2001·Stroke; a Journal of Cerebral Circulation·A HouseA Vail
Apr 12, 2001·Journal of Clinical Epidemiology·R Bender, S Lange
Apr 24, 2001·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·R C ArnauR Bramson
Jun 1, 2004·The American Journal of Psychiatry·Linda S WilliamsRalph W Swindle
Oct 12, 2005·Annals of Neurology·Dale C HesdorfferOlafur Kjartansson
Apr 25, 2006·Lancet Neurology·Frank G GilliamAndres M Kanner
Jul 15, 2006·Epilepsy & Behavior : E&B·Magdalena SzaflarskiRonnie D Horner
Mar 14, 2009·The Neurologist·Irene García-MoralesAndrés M Kanner
Jan 5, 2011·BMC Health Services Research·Mary Jo PughLewis E Kazis
Jul 12, 2011·Epilepsy & Behavior : E&B·Hamada HamidMarco Mula
Aug 14, 2012·Annals of Neurology·Dale C HesdorfferW Allen Hauser

❮ Previous
Next ❯

Citations

Mar 22, 2014·Current Neurology and Neuroscience Reports·Heidi M Munger Clary
Sep 17, 2016·Pharmacological Reports : PR·Barbara Błaszczyk, Stanisław J Czuczwar
Sep 27, 2018·Expert Opinion on Pharmacotherapy·Marco Mula
Jan 31, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·Yu A YakovlevaE L Rukavitsyna
Jan 9, 2018·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Ciaran LaneBernd Pohlmann-Eden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.